Cardiovascular Disease
News on molecular diagnostics, pharmacogenomics tests for coronary artery disease, congenital heart defects, and more.
Cardio Diagnostics Publishes Validation Data for Molecular Coronary Heart Disease Test
The new study in the Journal of the American Heart Association shows that the firm's machine learning-based genetic-epigenetic approach can help diagnose coronary heart disease.
In future studies, the firm must show that its Lp(a)-lowering siRNA therapy lepodisiran can help patients avoid major cardiovascular events.
Amgen Testing Clinical Outcomes of Promising Lp(a)-Targeting Cardiovascular Drug in Phase III Trial
Premium
While elevated Lp(a) has been linked with risk of cardiovascular disease, Amgen is hoping to shed light on whether lowering it improves patients' outcomes.
Eli Lilly Scoops Up Beam's Opt-in Rights to Verve's Base-Editing Cardiovascular Genetic Medicines
Lilly will pay Beam $200 million upfront and make an equity investment for opt-in rights to Verve's programs targeting PCSK9, ANGPTL3, and an undisclosed target.
Tenaya Therapeutics to Start Gene Therapy Trial for Genetic Form of Cardiomyopathy
The FDA cleared the company's IND application for TN-401, a gene therapy for PKP2-associated arrhythmogenic right ventricular cardiomyopathy.